9780781762731

Psychotropic Drug Handbook

by ; ; ;
  • ISBN13:

    9780781762731

  • ISBN10:

    0781762731

  • Edition: 8th
  • Format: Spiral Bound
  • Copyright: 2006-03-15
  • Publisher: LWW

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

  • Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $85.32 Save up to $8.53
  • Rent Book $76.79
    Add to Cart Free Shipping

    TERM
    PRICE
    DUE

Supplemental Materials

What is included with this book?

  • The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
  • The Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Summary

Gaining a solid foundation in psychopharmacotherapy is essential for your success in clinical practice. This well-referenced, evidence-based handbook provides the detailed information you need across a wide range of psychotropic drugs, including mood stabilizers, antidepressants, and more. The new edition features expanded and extensively updated chapters on antipsychotics, antianxiety agents, hypnotics, medications used in treating alcoholism and other substance dependencies, and electroconvulsive therapy.

Table of Contents

Antipsychotics
1(139)
Second-Generation Antipsychotics
6(49)
First-Generation Antipsychotics
55(85)
References
116(24)
Antidepressants
140(86)
Selective Serotonin Reuptake Inhibitors
142(24)
Third-Generation Antidepressants
166(16)
Tricyclic Antidepressants
182(17)
Monoamine Oxidase Inhibitors
199(11)
Benzodiazepines
210(1)
CNS Stimulants
211(15)
References
212(14)
Mood Stabilizers
226(70)
Lithium
227(29)
Valproate
256(9)
Carbamazepine
265(12)
Lamotrigine
277(5)
Miscellaneous Treatments
282(1)
Benzodiazepines
283(1)
Clonidine
283(1)
Gabapentin
284(1)
Omega-3 Fatty Acids
284(1)
Oxcarbazepine
285(1)
Topiramate
285(1)
Verapamil
285(11)
References
286(10)
Antianxiety Agents (Anxiolytics)
296(56)
Benzodiazepines
296(16)
Antidepressants
312(11)
β-Adrenergic Blocking Drugs
323(6)
Buspirone
329(5)
Miscellaneous Agents
334(18)
References
337(15)
Hypnotics
352(52)
Definition and Evaluation of Insomnia
352(4)
Nonpharmacologic Treatment of Insomnia
356(1)
Pharmacologic Treatment of Insomnia
357(26)
Benzodiazepine Receptor Agonists
360(16)
Non-Benzodiazepine Receptor Agonists
376(6)
Rational Prescribing of Hypnotics for Insomnia
382(1)
Dietary Supplements for Treatment of Insomnia
383(11)
Valerian
383(2)
Melatonin
385(3)
Tryptophan
388(1)
Rational Prescribing of Dietary Supplements for Insomnia
389(1)
Narcotherapy
389(5)
References
394(10)
Psychotropic Drug Treatment of Alcohol and Drug Dependence
404(36)
Disulfiram
404(10)
Naltrexone
414(7)
Acamprosate
421(3)
Methadone and L-α-Acetyl Methadol
424(4)
Buprenorphine
428(4)
Promising Drugs for Treatment of Substance Dependence
432(8)
References
433(7)
Drug Interactions
440(14)
Types of Drug Interactions
441(1)
Opportunities for Drug Interactions
442(6)
Evidence for Drug Interactions
448(3)
Explanations for Minimal Expression of Adverse Drug Interactions
451(3)
References
452(2)
Management of Acute Drug Withdrawal
454(52)
Ethanol Withdrawal
454(11)
Anxiolytic---Hypnotic Withdrawal
465(16)
Opiate Withdrawal
481(10)
Nicotine Withdrawal
491(5)
Central Nervous System Stimulant Withdrawal
496(10)
References
499(7)
Electroconvulsive Therapy
506(42)
Indications
506(1)
Efficacy
507(5)
Mechanism of Action
512(2)
Treatment-Related Variables
514(6)
Adverse Effects
520(6)
Devices Used in ECT
526(1)
Method of Administration
526(6)
Medications Used in ECT
532(3)
Rational Prescribing
535(13)
References
536(12)
Pharmacotherapy of Childhood and Adolescent Psychiatric Disorders
548(43)
Psychostimulants
548(12)
Antidepressants
560(11)
Antipsychotics
571(5)
Mood Stabilizers
576(2)
α2-Adrenergic Agonists
578(3)
Anxiolytics
581(10)
References
583(8)
Geriatrics
591(34)
Introduction
591(4)
Challenges and Guidelines of Psychotropic Drug Prescribing to the Geropsychiatric Patient
595(1)
Pharmacokinetic and Dynamic Changes Occurring with Normal Aging
596(4)
Mental Disorders and Other Treatable Conditions in the Elderly
600(2)
Dementia
602(8)
Overview of Drugs Used for the Treatment of Dementia
602(4)
Acetylcholinesterase Inhibitors
606(3)
NMDA Antagonist: Memantine
609(1)
Depression
610(5)
Nonpharmacologic Treatment
610(1)
Pharmacotherapy of Depression in AD
611(1)
Pharmacotherapy of Late-Life Depression
612(2)
Pharmacotherapy of Depression with Medical Illness
614(1)
Anxiety, Agitation, and Behavioral Problems
615(2)
Sleep Problems
617(1)
Summary
618(1)
References
618(7)
Appendix A Psychotropic Drug Product List 625(18)
Appendix B Pregnancy Risk and Lactation Categories 643(4)
Appendix C Psychotropic Drug Pharmacokinetic Parameters 647(10)
Appendix D Psychotropic Drug Interactions 657(20)
Index 677

Rewards Program

Write a Review